C-ENNZTornado Therapeutics
rapalogs, mTOR inhibition
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-ENNZ
C-ENNZC-ENNZrapalogs, mTOR inhibition
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Tornado Therapeutics rapalogs, mTOR inhibition
Tornado Therapeutics, a Cambrian Bio PipeCo, is developing safer, more effective rapalogs to treat disease and extend healthy lifespan. Its portfolio includes multiple compounds described as more potent inhibitors of TORC1 and TORC2 than first-generation rapalogs. The site lists programs including TOR-101 and TOR-103 across healthspan, intrinsic capacity, oncology, and respiratory tract infections.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Tornado Therapeutics — Far from goals · Bottom quartile. Derived deterministically from 2 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…
Source: Deterministic